Bausch Health Cos EBITDA 2010-2023 | BHC
Bausch Health Cos ebitda from 2010 to 2023. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Bausch Health Cos Annual EBITDA
(Millions of US $) |
| 2023 |
$2,292 |
| 2022 |
$1,947 |
| 2021 |
$2,057 |
| 2020 |
$2,562 |
| 2019 |
$1,935 |
| 2018 |
$514 |
| 2017 |
$3,111 |
| 2016 |
$2,418 |
| 2015 |
$4,139 |
| 2014 |
$3,685 |
| 2013 |
$1,696 |
| 2012 |
$1,102 |
| 2011 |
$940 |
| 2010 |
$166 |
| 2009 |
$319 |
Bausch Health Cos Quarterly EBITDA
(Millions of US $) |
| 2023-12-31 |
$692 |
| 2023-09-30 |
$343 |
| 2023-06-30 |
$739 |
| 2023-03-31 |
$518 |
| 2022-12-31 |
$129 |
| 2022-09-30 |
$601 |
| 2022-06-30 |
$558 |
| 2022-03-31 |
$659 |
| 2021-12-31 |
$743 |
| 2021-09-30 |
$973 |
| 2021-06-30 |
$146 |
| 2021-03-31 |
$195 |
| 2020-12-31 |
$439 |
| 2020-09-30 |
$909 |
| 2020-06-30 |
$470 |
| 2020-03-31 |
$744 |
| 2019-12-31 |
$-570 |
| 2019-09-30 |
$866 |
| 2019-06-30 |
$803 |
| 2019-03-31 |
$836 |
| 2018-12-31 |
$588 |
| 2018-09-30 |
$838 |
| 2018-06-30 |
$560 |
| 2018-03-31 |
$-1,472 |
| 2017-12-31 |
$548 |
| 2017-09-30 |
$770 |
| 2017-06-30 |
$865 |
| 2017-03-31 |
$928 |
| 2016-12-31 |
$886 |
| 2016-09-30 |
$-123 |
| 2016-06-30 |
$837 |
| 2016-03-31 |
$818 |
| 2015-12-31 |
$887 |
| 2015-09-30 |
$1,195 |
| 2015-06-30 |
$1,069 |
| 2015-03-31 |
$989 |
| 2014-12-31 |
$983 |
| 2014-09-30 |
$1,158 |
| 2014-06-30 |
$774 |
| 2014-03-31 |
$770 |
| 2013-12-31 |
$653 |
| 2013-09-30 |
$82 |
| 2013-06-30 |
$493 |
| 2013-03-31 |
$468 |
| 2012-12-31 |
$237 |
| 2012-09-30 |
$274 |
| 2012-06-30 |
$308 |
| 2012-03-31 |
$283 |
| 2011-12-31 |
$211 |
| 2011-09-30 |
$280 |
| 2011-06-30 |
$248 |
| 2011-03-31 |
$201 |
| 2010-12-31 |
$101 |
| 2010-09-30 |
$-79 |
| 2010-06-30 |
$88 |
| 2010-03-31 |
$56 |
| 2009-12-31 |
$104 |
| 2009-09-30 |
$101 |
| 2009-06-30 |
$39 |
| 2009-03-31 |
$75 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$3.183B |
$8.757B |
|
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|
